PB2000: A COMPREHENSIVE NGS PANEL APPROACH FOR CLINICAL GENOMIC ANALYSIS IN HAEMATOLOGICAL MALIGNANCY

PB2000: A COMPREHENSIVE NGS PANEL APPROACH FOR CLINICAL GENOMIC ANALYSIS IN HAEMATOLOGICAL MALIGNANCY

Bibliographic Details
Main Authors:	Joanne Mason, Anna Skowronska, Natalie Barrows, David Hill, Paula Page, Angela Hamblin, Sam Clokie, Andrew Feber, Robert Hastings, Nicholas Cross
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000974816.76738.e4

Similar Items

PB1809: COMPARISON OF OPTICAL GENOME MAPPING WITH STANDARD OF CARE TESTING TO INVESTIGATE GENOMIC ABNORMALITIES IN HAEMATOLOGICAL MALIGNANCIES: THE EXPERIENCE OF CENTRAL AND SOUTH GENOMIC LABORATORY HUB, UK
by: Mariela Muraru, et al.
Published: (2023-08-01)

Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design.
by: Almudena Aguilera-Diaz, et al.
Published: (2020-01-01)

PB2363: REPORTING LANGUAGE IN HAEMATOLOGICAL MALIGNANCIES
by: S. Watt, et al.
Published: (2022-06-01)

Application of Newly Customized Myeloid NGS Panel in the Diagnosis of Myeloid Malignancies
by: Alkhatabi HA, et al.
Published: (2024-01-01)

Targeting hypoxia in solid and haematological malignancies
by: Bill Harris, et al.
Published: (2022-11-01)

A panel of cancer-testis genes exhibiting broad-spectrum expression in haematological malignancies
by: Liggins, A, et al.
Published: (2010)

A panel of cancer-testis genes exhibiting broad-spectrum expression in haematological malignancies.
by: Liggins, A, et al.
Published: (2010)

Immunotherapy and immunomodulation for haematological malignancies
by: Mussai, F, et al.
Published: (2012)

PanelDesign: Integrating Epidemiological Information into the Design of Diagnostic NGS Gene Panels
by: Jörg Schmidtke, et al.
Published: (2022-04-01)

Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1
by: Leora Witkowski, et al.
Published: (2020-04-01)

A Review of the Application of mNGS in Hematologic Malignancy
by: Luyao Shi, et al.
Published: (2023-12-01)

Identification of Novel Mutations by Targeted NGS Panel in Patients with Hyperferritinemia
by: Giulia Ravasi, et al.
Published: (2021-11-01)

Key considerations for comprehensive validation of an RNA fusion NGS panel
by: Subit Barua, et al.
Published: (2020-08-01)

The expression of phosphorylated KDR in haematological malignancies
by: Pillai, G, et al.
Published: (2003)

Bone marrow inflammation in haematological malignancies
by: de Jong, M, et al.
Published: (2024)

Clinical Proteomics of Biofluids in Haematological Malignancies
by: Katie Dunphy, et al.
Published: (2021-07-01)

Immune-epigenetic crosstalk in haematological malignancies
by: Hera Wong, et al.
Published: (2023-09-01)

Role of tumour angiogenesis in haematological malignancies
by: Michael Medinger, et al.
Published: (2014-11-01)

Haematological Malignancy Presenting in an Unusual Manner
by: Ponvijaya Muthuswamy Yadav, et al.
Published: (2022-09-01)

Targeting translation factors in haematologic malignancies.
by: Lee, Janice Siu Hui.
Published: (2011)

Cap-independent translation in Haematological Malignancies
by: Emilie eHorvilleur, et al.
Published: (2015-12-01)

PB2459: AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION OUTCOMES OF HAEMATOLOGIC MALIGNANCIES COMPLICATED BY AUTOIMMUNE DISEASES
by: Ying Kang, et al.
Published: (2023-08-01)

PB2390: STUDY OF GENETIC ALTERATIONS USING A CUSTOM LYMPHOID TARGETED NGS PANEL IN PATIENTS WITH FOLLICULAR LYMPHOMA: A PILOT STUDY
by: Евгений Куневич, et al.
Published: (2023-08-01)

NGS amplification panel for HBV (Hepadnaviridae: <i>Orthohepadnavirus</i>) sequencing
by: Mikhail D. Chanyshev, et al.
Published: (2024-03-01)

Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia
by: Nerea Vega-Garcia, et al.
Published: (2020-11-01)

Clinical utility of custom-designed NGS panel testing in pediatric tumors
by: Lea F. Surrey, et al.
Published: (2019-05-01)

Statistical model based gender prediction for targeted NGS clinical panels
by: Palani Kannan Kandavel, et al.
Published: (2017-12-01)

PB2707: ESMO-MAGNITUDE OF CLINICAL BENEFIT SCALE FOR HAEMATOLOGICAL MALIGNANCIES (ESMO-MCBS:H) VERSION 1.0
by: Barbara Kiesewetter, et al.
Published: (2023-08-01)

Gene silencing by DNA methylation in haematological malignancies.
by: Boultwood, J, et al.
Published: (2007)

HDAC inhibitor-based therapies and haematological malignancy.
by: Stimson, L, et al.
Published: (2009)

Assessment of Seasonality in Eosinophilic Dermatosis of Haematological Malignancy
by: Aurore Brun, et al.
Published: (2024-02-01)

Ferroptosis in Haematological Malignancies and Associated Therapeutic Nanotechnologies
by: Rachel L. Mynott, et al.
Published: (2023-04-01)

Components of the Lectin Pathway of Complement in Haematologic Malignancies
by: Maciej Cedzyński, et al.
Published: (2020-07-01)

Beta-D-Glucan in Patients with Haematological Malignancies
by: Malgorzata Mikulska, et al.
Published: (2021-12-01)

PARP Inhibitors and Haematological Malignancies—Friend or Foe?
by: Kathryn A. Skelding, et al.
Published: (2021-10-01)

Opportunistic infections in patients with haematological malignancies in Nigeria
by: Bassey Ewa Ekeng, et al.
Published: (2022-01-01)

Risk factors for haemorrhage in patients with haematological malignancies
by: Estcourt, LJ
Published: (2014)

Hypomagnesaemia in critically ill patients with haematological malignancies
by: Silvio A. Ñamendys-Silva, et al.
Published: (2014-07-01)

Biosimilars for Haematologic Malignancies: The Path to Sustainable Care
by: Paul Cornes, et al.
Published: (2017-08-01)

PB2559: VARIEGATE PORPHYRIA CONFIRMED BY NGS AND TREATED WITH GIVOSIRAN - CASE PRESENTATION
by: Georgeta Daniela Georgescu
Published: (2023-08-01)